Management of antiplatelet therapy in patients undergoing elective invasive procedures. Proposals from the French Working Group on perioperative haemostasis (GIHP) and the French Study Group on thrombosis and haemostasis (GFHT). In collaboration with the French Society for Anaesthesia and Intensive Care Medicine (SFAR)
| Autor: | Anne Godier, Pierre Fontana, Serge Motte, Annick Steib, Fanny Bonhomme, Sylvie Schlumberger, Thomas Lecompte, Nadia Rosencher, Sophie Susen, André Vincentelli, Yves Gruel, Pierre Albaladejo, Jean-Philippe Collet, P. Albaladejo, S. Belisle, N. Blais, F. Bonhomme, A. Borel-Derlon, J.Y. Borg, J.-L. Bosson, A. Cohen, J.-P. Collet, E. de Maistre, D. Faraoni, P. Fontana, D. Garrigue Huet, A. Godier, Y. Gruel, J. Guay, J.F. Hardy, Y. Huet, B. Ickx, S. Laporte, D. Lasne, J.H. Levy, J. Llau, G. Le Gal, T. Lecompte, S. Lessire, D. Longrois, S. Madi-Jebara, E. Marret, J.L. Mas, M. Mazighi, P. Mismetti, P.E. Morange, S. Motte, F. Mullier, N. Nathan, P. Nguyen, Y. Ozier, G. Pernod, N. Rosencher, S. Roullet, P.M. Roy, C.M. Samama, S. Schlumberger, J.F. Schved, P. Sié, A. Steib, S. Susen, E. van Belle, P. van Der Linden, A. Vincentelli, P. Zufferey |
|---|---|
| Přispěvatelé: | UCL - (MGD) Service d'anesthésiologie, UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Laboratoire de biologie clinique |
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
Prasugrel Blood Loss Surgical 030204 cardiovascular system & hematology Critical Care and Intensive Care Medicine Perioperative Care Coronary artery disease 03 medical and health sciences 0302 clinical medicine medicine Humans 030212 general & internal medicine Intensive care medicine Aspirin business.industry Bleeding Antiplatelet agents Généralités Thrombosis General Medicine Perioperative medicine.disease Clopidogrel Hemostasis Surgical Discontinuation Anesthesiology and Pain Medicine Elective Surgical Procedures Anesthesia Surgery business Regional anaesthesia Ticagrelor Platelet Aggregation Inhibitors medicine.drug |
| Zdroj: | Anaesthesia, critical care & pain medicine, Vol. 37, no. 4, p. 379-389 (2018) Anaesthesia Critical Care and Pain Medicine, 37 (4 |
| Popis: | The French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Haemostasis and Thrombosis (GFHT) in collaboration with the French Society for Anaesthesia and Intensive Care Medicine (SFAR) drafted up-to-date proposals for the management of antiplatelet therapy in patients undergoing elective invasive procedures. The proposals were discussed and validated by a vote; all proposals but one could be assigned with a high strength. The management of antiplatelet therapy is based on their indication and the procedure. The risk of bleeding related to the procedure can be divided into high, moderate and low categories depending on the possibility of performing the procedure in patients receiving antiplatelet agents (none, monotherapy and dual antiplatelet therapy respectively). If discontinuation of antiplatelet therapy is indicated before the procedure, a last intake of aspirin, clopidogrel, ticagrelor and prasugrel 3, 5, 5 and 7 days before surgery respectively is proposed. The thrombotic risk associated with discontinuation should be assessed according to each specific indication of antiplatelet therapy and is higher for patients receiving dual therapy for coronary artery disease (with further refinements based on a few well-accepted items) than for those receiving monotherapy for cardiovascular prevention, for secondary stroke prevention or for lower extremity arterial disease. These proposals also address the issue of the potential role of platelet functional tests and consider management of antiplatelet therapy for regional anaesthesia, including central neuraxial anaesthesia and peripheral nerve blocks, and for coronary artery surgery. SCOPUS: ar.j info:eu-repo/semantics/published |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|